These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 6599577

  • 1. [Studies on the serum levels of a carbohydrate antigen 19-9 (CA 19-9) in patients with ovarian cancer].
    Miyoshi T, Nishimura H, Ookura N, Morisaki H, Kobayashi H, Tasaki T, Ushijima H, Yakushiji M.
    Igaku Kenkyu; 1984 Dec; 54(8):796-800. PubMed ID: 6599577
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Clinical significance of cancer antigen 125 (CA 125) in ovarian cancer.
    Crombach G, Zippel HH, Würz H.
    Cancer Detect Prev; 1985 Dec; 8(1-2):135-9. PubMed ID: 3864535
    [Abstract] [Full Text] [Related]

  • 4. [CA 125 in the diagnosis and evaluation of the efficacy of the treatment of cancer of the ovaries].
    Sagan DL, Chebotareva ED, Evtushenko GV.
    Med Radiol (Mosk); 1989 Jun; 34(6):39-42. PubMed ID: 2739519
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Clinical usefulness of monoclonal antibody, CA 125 and CA 19-9 in ovarian cancer].
    Saitoh S, Nakanishi A, Noda T, Ando Y, Katakami Y, Kiyozuka Y, Moriyama I, Ichijo M.
    Nihon Gan Chiryo Gakkai Shi; 1984 Dec 20; 19(10):2327-35. PubMed ID: 6598184
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [A monoclonal antibody RIA as an antigenic determinant (CA 125) in ovarian cancer patients].
    Lian LJ.
    Zhonghua Fu Chan Ke Za Zhi; 1985 Sep 20; 20(5):257-60, 317. PubMed ID: 2417787
    [No Abstract] [Full Text] [Related]

  • 11. [Clinical evaluation of a cancer antigen CA125 associated with ovarian cancer. (III) Serum CA125 levels in patients with ovarian cancer and other gynecological tumors].
    Suzuki M, Sekiguchi I, Tamada T, Sakurabayashi I, Kawai T.
    Rinsho Byori; 1985 Feb 20; 33(2):173-7. PubMed ID: 3858562
    [No Abstract] [Full Text] [Related]

  • 12. [Clinical significance of CA 19-9 as a tumor marker for gynecologic malignancies].
    Inoue M, Saitoh J, Abe Y, Inoue Y, Ueda G, Tanizawa O, Gamoh Y, Dan A, Satoh T.
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Nov 20; 37(11):2411-4. PubMed ID: 3865972
    [No Abstract] [Full Text] [Related]

  • 13. [Detection of CA-125 antigen (non-mucinous ovarian cancer antigen)-- in serum of patients with gynecological malignancies].
    Sakamoto S, Kawana H, Shimizu K, Ishihara T, Ueda K, Usman SM, Uchida S, Kawagoe K, Kihara K, Kubo H.
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Aug 20; 36(8):1261-2. PubMed ID: 6595322
    [No Abstract] [Full Text] [Related]

  • 14. Ca-125 levels in the conditioned media of the gynecological tumor cell lines.
    Ishiwata I, Ishiwata C.
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Jan 20; 37(1):147-8. PubMed ID: 3855943
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Significance of CA-125 antigen in the monitoring of therapy and clinical course of ovarian cancer].
    Pulay T, Csömör S.
    Orv Hetil; 1987 Dec 13; 128(50):2615-9. PubMed ID: 3323994
    [No Abstract] [Full Text] [Related]

  • 20. Monoclonal antibodies MA54 and MA61 as potential reagents in the prognosis of patients with ovarian cancer.
    Kobayashi H, Ohi H, Sugimura M, Shinohara H, Terao T.
    Gynecol Oncol; 1993 Apr 13; 49(1):80-5. PubMed ID: 8482565
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.